Analytical Data
-
基因名
CDHH
- Application
-
别名
CDHH；CDHH；Cadherin-13
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P55290
-
表达区间
139-693aa
-
氨基酸序列
SI VVSPILIPEN QRQPFPRDVG KVVDSDRPER SKFRLTGKGV DQEPKGIFRI NENTGSVSVT RTLDREVIAV YQLFVETTDV NGKTLEGPVP LEVIVIDQND NRPIFREGPY IGHVMEGSPT GTTVMRMTAF DADDPATDNA LLRYNIRQQT PDKPSPNMFY IDPEKGDIVT VVSPALLDRE TLENPKYELI IEAQDMAGLD VGLTGTATAT IMIDDKNDHS PKFTKKEFQA TVEEGAVGVI VNLTVEDKDD PTTGAWRAAY TIINGNPGQS FEIHTNPQTN EGMLSVVKPL DYEISAFHTL LIKVENEDPL VPDVSYGPSS TATVHITVLD VNEGPVFYPD PMMVTRQEDL SVGSVLLTVN ATDPDSLQHQ TIRYSVYKDP AGWLNINPIN GTVDTTAVLD RESPFVDNSV YTALFLAIDS GNPPATGTGT LLITLEDVND NAPFIYPTVA EVCDDAKNLS VVILGASDKD LHPNTDPFKF EIHKQAVPDK VWKISKINNT HALVSLLQNL NKANYNLPIM VTDSGKPPMT NITDLRVQVC SCRNSKVDCN AAG
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on CDHH recombinant protein (Cystathionine β-synthase with a dual function in heme degradation) has emerged from the necessity to understand its role in various biological processes and its potential implications in disease mechanisms. CDHH, a protein of interest due to its involvement in heme metabolism, is crucial for maintaining cellular homeostasis and responding to oxidative stress. Impaired function of CDHH has been linked to several pathologies, including neurodegenerative diseases and certain types of cancers. As a result, scientists are focusing on recombinant forms of CDHH to dissect its functional properties and interactions within cellular environments. These recombinant proteins allow for detailed structural and functional studies, facilitating insights into the enzyme's catalytic mechanisms and its regulatory pathways. Moreover, the ability to produce CDHH in a controlled laboratory setting opens avenues for therapeutic applications, including the development of novel treatments that could mitigate the effects of diseases associated with heme imbalance. Overall, the exploration of CDHH recombinant protein represents a significant stride in biochemical research, potentially leading to innovative strategies in disease management and therapeutic interventions.
